INIO – Innio NV

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=INIO#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

INIO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

3.89

Margin Of Safety %

-66

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

37.37

Target Price

Analyst Recom

Performance Q

Upside

N/A

Beta

Ticker: INIO

9 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-15	INIO	34.74	N/A	N/A	0
2026-06-16	INIO	34.21	N/A	N/A	0
2026-06-17	INIO	35	N/A	N/A	0
2026-06-18	INIO	37.38	N/A	N/A	0
2026-06-22	INIO	41.1	N/A	N/A	0
2026-06-23	INIO	38.3	N/A	N/A	0
2026-06-24	INIO	36.4	N/A	N/A	0
2026-06-25	INIO	38.25	N/A	N/A	0
2026-06-26	INIO	37.36	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

9 items 1 of 1

9 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-06-15	INIO	34.74	-	-	-
2026-06-16	INIO	34.19	-	-	-
2026-06-17	INIO	34.98	-	-	-
2026-06-18	INIO	37.39	-	-	-
2026-06-22	INIO	41.06	-	-	-
2026-06-23	INIO	38.31	-	-	-
2026-06-24	INIO	36.51	-	-	-
2026-06-25	INIO	38.37	-	-	-
2026-06-26	INIO	37.37	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

9 items 1 of 1

9 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-06-15	INIO	-13.78	0	0
2026-06-16	INIO	-13.77	0	0
2026-06-17	INIO	-13.77	0	0
2026-06-18	INIO	-13.77	0	0
2026-06-22	INIO	-13.77	0	0
2026-06-23	INIO	-13.77	0	0
2026-06-24	INIO	-13.77	0	0
2026-06-25	INIO	-13.77	0	0
2026-06-26	INIO	-13.77	0	3.89
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

9 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=INIO 589 360 ]

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

-13.77

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

12.6

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

124.63

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.53

Return on Equity vs Sector %

36.6

Return on Equity vs Industry %

27.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=INIO 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=INIO 589 450 ]

◆ INIO Industrials

$37.29

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

10/25

Volume

11/15

Valuation

4/20

TP/AR

2/10

Options

0/10

RSI

57.9

Sup Dist

1.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

4/30

Estimates

2/20

Inst/Vol

0/15

Options

0/10

EPS Yr

EPS NY

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -66.2% upside

Quality

3/30

Valuation

2/30

Growth

0/25

Stability

0/10

LT Trend

0/5

Upside

-66.2%

Quality

MoS

-66%

INIO — P/E HistoricalSpecialty Industrial Machinery

INNIO N.V.

Sector: Industrials

Industry: Specialty Industrial Machinery

Employees: 5202

Innio N.V., through its subsidiaries, provides power generation equipment and services under the Jenbacher and Waukesha brands in Germany, rest of Europe, the United States, rest of North America, and internationally. It operates in two segments, Equipment and Services. The Equipment segment designs, manufactures, and sells new engines, product-related equipment, and related solutions for data center, power solutions, and compression end-markets. The Services segment provides aftermarket services through an engine's lifecycle, including service agreements, spare parts, overhauls, remanufacturing of engines and components, digital solutions, and service-related activities, as well as maintenance and replacement of parts, transactional services, and multi-year contracts. It also operates Myplant, an AI-enabled fleet management platform. Innio N.V. was founded in 2018 and is headquartered in Munich, Germany. Innio N.V. operates as a subsidiary of AI Alpine (Luxembourg) S.à r.l.

INIO

Latest News

—

Caricamento notizie per INIO…

stock quote shares INIO – Innio NV Stock Price stock today

news today INIO – Innio NV stock forecast ,stock prediction 2023 2024 2025

marketwatch INIO – Innio NV yahoo finance google finance

stock history INIO – Innio NV invest stock market

stock prices INIO premarket after hours

ticker INIO fair value insiders trading

EVO – Evotec SE

EVO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.02

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

-0.37

EPS This/Next Y

0.54

Price

2.74

Target Price

4.3

Analyst Recom

1.89

Performance Q

11.38

Upside

-904.7%

Beta

1.93

Ticker: EVO

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-02	EVO	2.95	N/A	N/A	0
2026-06-03	EVO	2.89	N/A	N/A	0
2026-06-04	EVO	2.96	N/A	N/A	0
2026-06-05	EVO	2.8	N/A	N/A	0
2026-06-08	EVO	2.81	N/A	N/A	0
2026-06-09	EVO	2.76	N/A	N/A	0
2026-06-10	EVO	2.62	N/A	N/A	0
2026-06-11	EVO	2.71	N/A	N/A	0
2026-06-12	EVO	2.73	N/A	N/A	0
2026-06-15	EVO	2.8	N/A	N/A	0
2026-06-16	EVO	2.69	N/A	N/A	0
2026-06-17	EVO	2.61	N/A	N/A	0
2026-06-18	EVO	2.56	N/A	N/A	0
2026-06-22	EVO	2.62	N/A	N/A	0
2026-06-23	EVO	2.64	N/A	N/A	0
2026-06-24	EVO	2.69	N/A	N/A	0
2026-06-25	EVO	2.72	N/A	N/A	0
2026-06-26	EVO	2.76	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-06-01	EVO	3.08	-	104.7	-0.70
2026-06-02	EVO	2.95	-	109.0	-0.70
2026-06-03	EVO	2.90	-	106.9	-0.70
2026-06-04	EVO	2.96	-	103.2	-0.70
2026-06-05	EVO	2.79	-	109.6	-0.70
2026-06-08	EVO	2.82	-	107.0	-0.70
2026-06-09	EVO	2.74	-	109.4	-0.70
2026-06-10	EVO	2.61	-	110.6	-0.70
2026-06-11	EVO	2.70	-	104.4	-0.70
2026-06-12	EVO	2.72	-	105.0	-0.70
2026-06-15	EVO	2.82	-	103.8	-0.70
2026-06-16	EVO	2.68	-	110.6	-0.70
2026-06-17	EVO	2.62	-	109.3	-0.70
2026-06-18	EVO	2.56	-	111.9	-0.70
2026-06-22	EVO	2.62	-	106.1	-0.70
2026-06-23	EVO	2.62	-	108.1	-0.70
2026-06-24	EVO	2.69	-	107.0	-0.70
2026-06-25	EVO	2.72	-	107.7	-0.70
2026-06-26	EVO	2.74	-	103.8	-0.70
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-06-02	EVO	0.00	-22.30	0.02
2026-06-03	EVO	0.00	-22.30	0.02
2026-06-04	EVO	0.00	-22.30	0.02
2026-06-05	EVO	0.00	-22.30	0.02
2026-06-08	EVO	0.00	-21.30	0.02
2026-06-09	EVO	0.00	-21.30	0.02
2026-06-10	EVO	0.00	-21.30	0.02
2026-06-11	EVO	0.00	-21.30	0.02
2026-06-12	EVO	0.00	-21.30	0.02
2026-06-15	EVO	0.00	-18.73	0.02
2026-06-16	EVO	0.00	-18.73	0.02
2026-06-17	EVO	0.00	-18.73	0.02
2026-06-18	EVO	0.00	-18.73	0.02
2026-06-22	EVO	0.00	-19.71	0.02
2026-06-23	EVO	0.00	-19.71	0.02
2026-06-24	EVO	0.00	-19.71	0.02
2026-06-25	EVO	0.00	-19.71	0.02
2026-06-26	EVO	0.00	-19.71	0.02
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.09

Avg. EPS Est. Next Quarter

-0.07

Insider Transactions

Institutional Transactions

-19.71

Beta

1.93

Average Sales Estimate Current Quarter

175

Average Sales Estimate Next Quarter

191

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

89.7

Max Drawdown 5-Year %

-91.3

Target Price

4.3

P/E

Forward P/E

PEG

P/S

1.13

P/B

1.21

P/Free Cash Flow

EPS

-0.63

Average EPS Est. Cur. Y

-0.7

EPS Next Y. (Est.)

-0.16

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-26.08

Relative Volume

0.23

Return on Equity vs Sector %

-55.1

Return on Equity vs Industry %

-34.7

EPS 1 7Days Diff

-0.4

EPS 1 30Days Diff

-0.35

EBIT Estimation

103.8

◆ EVO Healthcare

$2.74

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

21/25

Volume

11/15

Valuation

12/20

TP/AR

1/10

Options

0/10

RSI

Range 1M

35.6%

Sup Dist

2.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

9/30

Estimates

0/20

Inst/Vol

2/15

Options

0/10

EPS Yr

-21.9%

EPS NY

83.9%

52W%

20.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +56.9% upside

Quality

2/30

Valuation

12/30

Growth

6/25

Stability

4/10

LT Trend

1/5

Upside

+56.9%

Quality

EVO — P/E HistoricalDrug Manufacturers - Specialty & Generic

Evotec SE

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 4526

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases. It is also developingcentral nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. In addition, it has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. Further, the company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. Evotec SE has strategic collaboration with Almirall, S.A. for the development of novel therapeutics for severe skin diseases, including a range of immune-mediated inflammatory conditions. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

EVO

Latest News

—

Caricamento notizie per EVO…

stock quote shares EVO – Evotec SE Stock Price stock today

news today EVO – Evotec SE stock forecast ,stock prediction 2023 2024 2025

marketwatch EVO – Evotec SE yahoo finance google finance

stock history EVO – Evotec SE invest stock market

stock prices EVO premarket after hours

ticker EVO fair value insiders trading

VJET – Voxeljet AG ADR

VJET — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.11

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.19

Price

Target Price

2.67

Analyst Recom

Performance Q

-45.29

Upside

N/A

Beta

1.07

Ticker: VJET

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-02	VJET	0.6401	N/A	N/A	0
2026-06-03	VJET	0.6401	N/A	N/A	0
2026-06-04	VJET	0.6401	N/A	N/A	0
2026-06-05	VJET	0.6401	N/A	N/A	0
2026-06-08	VJET	0.6401	N/A	N/A	0
2026-06-09	VJET	0.6401	N/A	N/A	0
2026-06-10	VJET	0.6401	N/A	N/A	0
2026-06-11	VJET	0.6401	N/A	N/A	0
2026-06-12	VJET	0.6401	N/A	N/A	0
2026-06-15	VJET	0.6401	N/A	N/A	0
2026-06-16	VJET	0.6401	N/A	N/A	0
2026-06-17	VJET	0.6401	N/A	N/A	0
2026-06-18	VJET	0.6401	N/A	N/A	0
2026-06-22	VJET	0.6401	N/A	N/A	0
2026-06-23	VJET	0.6401	N/A	N/A	0
2026-06-24	VJET	0.6401	N/A	N/A	0
2026-06-25	VJET	0.6401	N/A	N/A	0
2026-06-26	VJET	0.6401	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.49

Avg. EPS Est. Next Quarter

-0.3

Insider Transactions

Institutional Transactions

80.2

Beta

1.07

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.5

Max Drawdown 5-Year %

-98.7

Target Price

2.67

P/E

Forward P/E

PEG

P/S

0.18

P/B

0.38

P/Free Cash Flow

EPS

-1.2

Average EPS Est. Cur. Y

-1.62

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-34.59

Relative Volume

Return on Equity vs Sector %

-119.2

Return on Equity vs Industry %

-106.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

No data found for VJET

VJET — P/E HistoricalComputer Hardware

VJET

Latest News

—

Caricamento notizie per VJET…

stock quote shares VJET – Voxeljet AG ADR Stock Price stock today

news today VJET – Voxeljet AG ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch VJET – Voxeljet AG ADR yahoo finance google finance

stock history VJET – Voxeljet AG ADR invest stock market

stock prices VJET premarket after hours

ticker VJET fair value insiders trading

IMTX – Immatics N.V

IMTX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.03

Margin Of Safety %

Put/Call OI Ratio

1.5

EPS Next Q Diff

EPS Last/This Y

-0.12

EPS This/Next Y

0.05

Price

9.52

Target Price

18.39

Analyst Recom

Performance Q

-2.56

Upside

-369.0%

Beta

1.35

Ticker: IMTX

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-02	IMTX	10.05	0.08	0.42	1000
2026-06-03	IMTX	10.21	0.08	0.42	1000
2026-06-04	IMTX	10.19	0.08	0.42	1000
2026-06-05	IMTX	9.79	0.09	999.99	1013
2026-06-08	IMTX	9.23	0.09	999.99	1013
2026-06-09	IMTX	9.16	0.09	999.99	1014
2026-06-10	IMTX	8.86	0.11	53.50	1034
2026-06-11	IMTX	9.05	0.17	999.99	1087
2026-06-12	IMTX	9.35	0.22	0.00	1135
2026-06-15	IMTX	9.44	0.21	4.00	1150
2026-06-16	IMTX	9.08	0.21	0.00	1153
2026-06-17	IMTX	9.55	0.21	999.99	1156
2026-06-18	IMTX	9.76	0.27	16.60	1210
2026-06-22	IMTX	9.78	0.27	0.67	353
2026-06-23	IMTX	9.89	0.27	4.33	353
2026-06-24	IMTX	10.03	0.68	999.99	471
2026-06-25	IMTX	9.52	0.88	999.99	527
2026-06-26	IMTX	9.52	1.50	0.00	700
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-06-01	IMTX	11.13	28.6	-	-1.95
2026-06-02	IMTX	10.02	28.6	-	-1.95
2026-06-03	IMTX	10.20	28.6	-	-1.95
2026-06-04	IMTX	10.19	28.6	-	-1.95
2026-06-05	IMTX	9.81	28.7	-	-1.95
2026-06-08	IMTX	9.21	28.7	-	-1.95
2026-06-09	IMTX	9.15	28.7	-	-1.95
2026-06-10	IMTX	8.86	28.7	-	-1.95
2026-06-11	IMTX	9.06	28.7	-	-1.95
2026-06-12	IMTX	9.38	28.7	-	-1.95
2026-06-15	IMTX	9.43	28.7	-	-1.95
2026-06-16	IMTX	9.09	28.7	-	-1.95
2026-06-17	IMTX	9.52	28.7	-	-1.95
2026-06-18	IMTX	9.77	28.7	-	-1.95
2026-06-22	IMTX	9.78	28.7	-	-1.95
2026-06-23	IMTX	9.91	28.7	-	-1.95
2026-06-24	IMTX	10.03	28.7	-	-1.95
2026-06-25	IMTX	9.53	28.7	-	-1.95
2026-06-26	IMTX	9.52	28.7	-	-1.95
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-06-02	IMTX	0.00	5.25	4.28
2026-06-03	IMTX	0.00	5.25	4.28
2026-06-04	IMTX	0.00	5.25	4.28
2026-06-05	IMTX	0.00	5.25	4.28
2026-06-08	IMTX	0.00	5.24	4.28
2026-06-09	IMTX	0.00	5.24	4.28
2026-06-10	IMTX	0.00	5.24	4.28
2026-06-11	IMTX	0.00	5.24	4.28
2026-06-12	IMTX	0.00	5.24	4.28
2026-06-15	IMTX	0.00	5.27	4.27
2026-06-16	IMTX	0.00	5.27	4.27
2026-06-17	IMTX	0.00	5.27	4.27
2026-06-18	IMTX	0.00	5.27	4.27
2026-06-22	IMTX	0.00	5.27	4.27
2026-06-23	IMTX	0.00	5.27	4.27
2026-06-24	IMTX	0.00	5.27	4.27
2026-06-25	IMTX	0.00	5.27	4.27
2026-06-26	IMTX	0.00	5.27	5.03
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

-0.5

Avg. EPS Est. Current Quarter

-0.48

Avg. EPS Est. Next Quarter

-0.5

Insider Transactions

Institutional Transactions

5.27

Beta

1.35

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

41.6

Max Drawdown 5-Year %

-77.4

Target Price

18.39

P/E

Forward P/E

PEG

P/S

29.46

P/B

2.48

P/Free Cash Flow

EPS

-1.97

Average EPS Est. Cur. Y

-1.95

EPS Next Y. (Est.)

-1.89

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-572.25

Relative Volume

0.5

Return on Equity vs Sector %

-74.4

Return on Equity vs Industry %

-57.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-1.95

EBIT Estimation

◆ IMTX Healthcare

$9.52

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

17/25

Volume

11/15

Valuation

10/20

TP/AR

2/10

Options

3/10

RSI

42.8

Range 1M

20.3%

Sup Dist

2.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

15/25

Growth

5/30

Estimates

0/20

Inst/Vol

6/15

Options

4/10

EPS Yr

-8.6%

EPS NY

52W%

58.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +93.2% upside

Quality

2/30

Valuation

14/30

Growth

1/25

Stability

8/10

LT Trend

3/5

Upside

+93.2%

Quality

IMTX — P/E HistoricalBiotechnology

Immatics N.V.

Sector: Healthcare

Industry: Biotechnology

Employees: 678

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes Anzu-cel (IMA203), a one-time infusion PRAME cell therapy, which is in Phase 2 trial; IMA203CD8, a cell therapy product that is in Phase 1 clinical trial; IMA204 that targets tumor stroma, which is in Phase 1 clinical trial; and Anzu-cel in combination with Moderna's PRAME cell therapy enhancer (mRNA-4203), which is in Phase 1 clinical trial. The company also develops TCR Bispecifics products, including IMA401 and IMA402, which is in Phase 1a clinical trial. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.

IMTX

Latest News

—

Caricamento notizie per IMTX…

stock quote shares IMTX – Immatics N.V Stock Price stock today

news today IMTX – Immatics N.V stock forecast ,stock prediction 2023 2024 2025

marketwatch IMTX – Immatics N.V yahoo finance google finance

stock history IMTX – Immatics N.V invest stock market

stock prices IMTX premarket after hours

ticker IMTX fair value insiders trading

FMS – Fresenius Medical Care AG ADR

FMS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.58

Margin Of Safety %

Put/Call OI Ratio

1.01

EPS Next Q Diff

0.04

EPS Last/This Y

0.64

EPS This/Next Y

0.83

Price

23.25

Target Price

24.54

Analyst Recom

Performance Q

3.8

Upside

79.9%

Beta

0.73

Ticker: FMS

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-02	FMS	20.56	0.62	999.99	3453
2026-06-03	FMS	20.9	0.62	999.99	3453
2026-06-04	FMS	21.93	0.62	999.99	3453
2026-06-05	FMS	22.02	0.62	0.00	3460
2026-06-08	FMS	21.78	0.62	0.00	3461
2026-06-09	FMS	22.35	0.62	0.02	3447
2026-06-10	FMS	22.26	0.63	2.00	3425
2026-06-11	FMS	22.39	0.63	999.99	3427
2026-06-12	FMS	23.03	0.63	0.16	3432
2026-06-15	FMS	23.45	0.71	1.82	3492
2026-06-16	FMS	23.75	0.70	0.11	3462
2026-06-17	FMS	23.57	0.70	13.00	3470
2026-06-18	FMS	23.58	0.69	0.50	3464
2026-06-22	FMS	23.5	1.00	0.48	2709
2026-06-23	FMS	23.7	1.00	0.48	2709
2026-06-24	FMS	23.84	0.99	60.00	2697
2026-06-25	FMS	23.26	1.01	999.99	2728
2026-06-26	FMS	23.25	1.01	999.99	2728
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-06-01	FMS	21.05	8.5	-125.8	2.46
2026-06-02	FMS	20.58	8.5	-124.2	2.46
2026-06-03	FMS	20.91	8.5	-81.2	2.46
2026-06-04	FMS	21.93	8.5	-48.3	2.46
2026-06-05	FMS	22.03	8.5	-78.5	2.46
2026-06-08	FMS	21.79	8.5	-96.0	2.46
2026-06-09	FMS	22.36	8.5	-50.3	2.46
2026-06-10	FMS	22.28	8.5	-84.7	2.46
2026-06-11	FMS	22.39	8.5	-76.8	2.46
2026-06-12	FMS	23.03	8.5	-63.9	2.46
2026-06-15	FMS	23.46	8.5	-80.2	2.46
2026-06-16	FMS	23.75	8.5	-90.6	2.55
2026-06-17	FMS	23.57	8.5	-112.5	2.55
2026-06-18	FMS	23.58	8.5	-105.2	2.55
2026-06-22	FMS	23.39	8.5	-107.1	2.55
2026-06-23	FMS	23.70	8.5	-81.8	2.55
2026-06-24	FMS	23.84	8.5	-88.4	2.55
2026-06-25	FMS	23.25	8.5	-122.2	2.55
2026-06-26	FMS	23.25	8.5	-50.6	2.55
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-06-02	FMS	0	-1.77	0.24
2026-06-03	FMS	0	-1.77	0.24
2026-06-04	FMS	0	-1.77	0.24
2026-06-05	FMS	0	-1.77	0.24
2026-06-08	FMS	0	-1.61	0.24
2026-06-09	FMS	0	-1.61	0.24
2026-06-10	FMS	0	-1.61	0.45
2026-06-11	FMS	0	-1.61	0.45
2026-06-12	FMS	0	-1.61	0.45
2026-06-15	FMS	0	-1.68	0.45
2026-06-16	FMS	0	-1.68	0.45
2026-06-17	FMS	0	-1.68	0.45
2026-06-18	FMS	0	-1.68	0.45
2026-06-22	FMS	0	-1.55	0.45
2026-06-23	FMS	0	-1.55	0.45
2026-06-24	FMS	0	-1.55	0.45
2026-06-25	FMS	0	-1.55	0.45
2026-06-26	FMS	0	-1.55	0.58
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.53

Avg. EPS Est. Current Quarter

0.49

Avg. EPS Est. Next Quarter

0.57

Insider Transactions

Institutional Transactions

-1.55

Beta

0.73

Average Sales Estimate Current Quarter

4744

Average Sales Estimate Next Quarter

4924

Fair Value

23.67

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

44.8

Max Drawdown 5-Year %

-68.7

Target Price

24.54

P/E

12.23

Forward P/E

9.25

PEG

2.26

P/S

0.51

P/B

0.82

P/Free Cash Flow

5.61

EPS

1.9

Average EPS Est. Cur. Y

2.55

EPS Next Y. (Est.)

3.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.88

Relative Volume

0.56

Return on Equity vs Sector %

-20.2

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.11

EBIT Estimation

-50.6

◆ FMS Healthcare

$23.24

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

6/20

Pullback

10/25

Volume

11/15

Valuation

14/20

TP/AR

0/10

Options

3/10

RSI

56.5

Range 1M

76.2%

Sup Dist

0.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

4/30

Estimates

4/20

Inst/Vol

1/15

Options

1/10

EPS Yr

-8.4%

EPS NY

52W%

35.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +111.7% upside

Quality

6/30

Valuation

19/30

Growth

4/25

Stability

3/10

LT Trend

3/5

Upside

+111.7%

Quality

MoS

FMS — P/E HistoricalMedical Care Facilities

Fresenius Medical Care AG

Sector: Healthcare

Industry: Medical Care Facilities

Employees: 108165

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

FMS

Latest News

—

Caricamento notizie per FMS…

stock quote shares FMS – Fresenius Medical Care AG ADR Stock Price stock today

news today FMS – Fresenius Medical Care AG ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch FMS – Fresenius Medical Care AG ADR yahoo finance google finance

stock history FMS – Fresenius Medical Care AG ADR invest stock market

stock prices FMS premarket after hours

ticker FMS fair value insiders trading

FMS – Fresenius Medical Care AG & Co. KGaA

FMS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.58

Margin Of Safety %

Put/Call OI Ratio

1.01

EPS Next Q Diff

0.04

EPS Last/This Y

0.64

EPS This/Next Y

0.83

Price

23.25

Target Price

24.54

Analyst Recom

Performance Q

3.8

Upside

79.9%

Beta

0.73

Ticker: FMS

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-02	FMS	20.56	0.62	999.99	3453
2026-06-03	FMS	20.9	0.62	999.99	3453
2026-06-04	FMS	21.93	0.62	999.99	3453
2026-06-05	FMS	22.02	0.62	0.00	3460
2026-06-08	FMS	21.78	0.62	0.00	3461
2026-06-09	FMS	22.35	0.62	0.02	3447
2026-06-10	FMS	22.26	0.63	2.00	3425
2026-06-11	FMS	22.39	0.63	999.99	3427
2026-06-12	FMS	23.03	0.63	0.16	3432
2026-06-15	FMS	23.45	0.71	1.82	3492
2026-06-16	FMS	23.75	0.70	0.11	3462
2026-06-17	FMS	23.57	0.70	13.00	3470
2026-06-18	FMS	23.58	0.69	0.50	3464
2026-06-22	FMS	23.5	1.00	0.48	2709
2026-06-23	FMS	23.7	1.00	0.48	2709
2026-06-24	FMS	23.84	0.99	60.00	2697
2026-06-25	FMS	23.26	1.01	999.99	2728
2026-06-26	FMS	23.25	1.01	999.99	2728
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-06-01	FMS	21.05	8.5	-125.8	2.46
2026-06-02	FMS	20.58	8.5	-124.2	2.46
2026-06-03	FMS	20.91	8.5	-81.2	2.46
2026-06-04	FMS	21.93	8.5	-48.3	2.46
2026-06-05	FMS	22.03	8.5	-78.5	2.46
2026-06-08	FMS	21.79	8.5	-96.0	2.46
2026-06-09	FMS	22.36	8.5	-50.3	2.46
2026-06-10	FMS	22.28	8.5	-84.7	2.46
2026-06-11	FMS	22.39	8.5	-76.8	2.46
2026-06-12	FMS	23.03	8.5	-63.9	2.46
2026-06-15	FMS	23.46	8.5	-80.2	2.46
2026-06-16	FMS	23.75	8.5	-90.6	2.55
2026-06-17	FMS	23.57	8.5	-112.5	2.55
2026-06-18	FMS	23.58	8.5	-105.2	2.55
2026-06-22	FMS	23.39	8.5	-107.1	2.55
2026-06-23	FMS	23.70	8.5	-81.8	2.55
2026-06-24	FMS	23.84	8.5	-88.4	2.55
2026-06-25	FMS	23.25	8.5	-122.2	2.55
2026-06-26	FMS	23.25	8.5	-50.6	2.55
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-06-02	FMS	0	-1.77	0.24
2026-06-03	FMS	0	-1.77	0.24
2026-06-04	FMS	0	-1.77	0.24
2026-06-05	FMS	0	-1.77	0.24
2026-06-08	FMS	0	-1.61	0.24
2026-06-09	FMS	0	-1.61	0.24
2026-06-10	FMS	0	-1.61	0.45
2026-06-11	FMS	0	-1.61	0.45
2026-06-12	FMS	0	-1.61	0.45
2026-06-15	FMS	0	-1.68	0.45
2026-06-16	FMS	0	-1.68	0.45
2026-06-17	FMS	0	-1.68	0.45
2026-06-18	FMS	0	-1.68	0.45
2026-06-22	FMS	0	-1.55	0.45
2026-06-23	FMS	0	-1.55	0.45
2026-06-24	FMS	0	-1.55	0.45
2026-06-25	FMS	0	-1.55	0.45
2026-06-26	FMS	0	-1.55	0.58
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.53

Avg. EPS Est. Current Quarter

0.49

Avg. EPS Est. Next Quarter

0.57

Insider Transactions

Institutional Transactions

-1.55

Beta

0.73

Average Sales Estimate Current Quarter

4744

Average Sales Estimate Next Quarter

4924

Fair Value

23.67

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

44.8

Max Drawdown 5-Year %

-68.7

Target Price

24.54

P/E

12.23

Forward P/E

9.25

PEG

2.26

P/S

0.51

P/B

0.82

P/Free Cash Flow

5.61

EPS

1.9

Average EPS Est. Cur. Y

2.55

EPS Next Y. (Est.)

3.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.88

Relative Volume

0.56

Return on Equity vs Sector %

-20.2

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.11

EBIT Estimation

-50.6

◆ FMS Healthcare

$23.24

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

6/20

Pullback

10/25

Volume

11/15

Valuation

14/20

TP/AR

0/10

Options

3/10

RSI

56.5

Range 1M

76.2%

Sup Dist

0.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

4/30

Estimates

4/20

Inst/Vol

1/15

Options

1/10

EPS Yr

-8.4%

EPS NY

52W%

35.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +111.7% upside

Quality

6/30

Valuation

19/30

Growth

4/25

Stability

3/10

LT Trend

3/5

Upside

+111.7%

Quality

MoS

FMS — P/E HistoricalMedical Care Facilities

Fresenius Medical Care AG

Sector: Healthcare

Industry: Medical Care Facilities

Employees: 108165

FMS

Latest News

—

Caricamento notizie per FMS…

stock quote shares FMS – Fresenius Medical Care AG & Co. KGaA Stock Price stock today

news today FMS – Fresenius Medical Care AG & Co. KGaA stock forecast ,stock prediction 2023 2024 2025

marketwatch FMS – Fresenius Medical Care AG & Co. KGaA yahoo finance google finance

stock history FMS – Fresenius Medical Care AG & Co. KGaA invest stock market

stock prices FMS premarket after hours

ticker FMS fair value insiders trading

No more stocks to show

INIO – Innio NV

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: INIO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

EVO – Evotec SE

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: EVO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y